Xie K - Search Results

1

Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis.

Huang C, Xie K. Huang C, et al. Among authors: xie k. Cytokine Growth Factor Rev. 2012 Feb-Apr;23(1-2):25-35. doi: 10.1016/j.cytogfr.2012.01.003. Epub 2012 Feb 16. Cytokine Growth Factor Rev. 2012. PMID: 22342309 Free PMC article. Review.

2

Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer.

Wang L, Guan X, Gong W, Yao J, Peng Z, Wei D, Wu TT, Huang S, Xie K. Wang L, et al. Among authors: xie k. Clin Exp Metastasis. 2005;22(3):205-13. doi: 10.1007/s10585-005-5684-3. Clin Exp Metastasis. 2005. PMID: 16158248

3

Transcriptional anti-angiogenesis therapy of human pancreatic cancer.

Xie K, Wei D, Huang S. Xie K, et al. Cytokine Growth Factor Rev. 2006 Jun;17(3):147-56. doi: 10.1016/j.cytogfr.2006.01.002. Epub 2006 Mar 3. Cytokine Growth Factor Rev. 2006. PMID: 16516532 Review.

4

Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.

Yuan P, Wang L, Wei D, Zhang J, Jia Z, Li Q, Le X, Wang H, Yao J, Xie K. Yuan P, et al. Among authors: xie k. Cancer. 2007 Dec 15;110(12):2682-90. doi: 10.1002/cncr.23092. Cancer. 2007. PMID: 17973266 Free article.

5

Nitric oxide and pancreatic cancer pathogenesis, prevention, and treatment.

Wang L, Xie K. Wang L, et al. Among authors: xie k. Curr Pharm Des. 2010;16(4):421-7. doi: 10.2174/138161210790232194. Curr Pharm Des. 2010. PMID: 20236070 Review.

6

Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis.

Gao Y, Jia Z, Kong X, Li Q, Chang DZ, Wei D, Le X, Suyun H, Huang S, Wang L, Xie K. Gao Y, et al. Among authors: xie k. Cancer Res. 2011 Aug 1;71(15):5182-93. doi: 10.1158/0008-5472.CAN-10-2016. Epub 2011 Jun 14. Cancer Res. 2011. PMID: 21673052 Free PMC article.

7

A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis.

Huang C, Qiu Z, Wang L, Peng Z, Jia Z, Logsdon CD, Le X, Wei D, Huang S, Xie K. Huang C, et al. Among authors: xie k. Cancer Res. 2012 Feb 1;72(3):655-65. doi: 10.1158/0008-5472.CAN-11-3102. Epub 2011 Dec 22. Cancer Res. 2012. PMID: 22194465 Free PMC article.

8

Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer.

Cui J, Jiang W, Wang S, Wang L, Xie K. Cui J, et al. Among authors: xie k. Curr Pharm Des. 2012;18(17):2464-71. doi: 10.2174/13816128112092464. Curr Pharm Des. 2012. PMID: 22372504 Review.

9

Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implications.

Kong X, Li L, Li Z, Xie K. Kong X, et al. Among authors: xie k. Cytokine Growth Factor Rev. 2012 Dec;23(6):343-56. doi: 10.1016/j.cytogfr.2012.06.006. Epub 2012 Jul 1. Cytokine Growth Factor Rev. 2012. PMID: 22749856 Free PMC article. Review.

10

The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis.

Li D, Wei P, Peng Z, Huang C, Tang H, Jia Z, Cui J, Le X, Huang S, Xie K. Li D, et al. Among authors: xie k. Clin Cancer Res. 2013 Jan 1;19(1):62-72. doi: 10.1158/1078-0432.CCR-12-1588. Epub 2012 Nov 7. Clin Cancer Res. 2013. PMID: 23136192 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,093 results

Search Page

Filters